Abstract
The versatility and potential of reductive cyclisation as a route to 5-membered N-heterocyclic structures of diverse complexity is demonstrated through selected examples.
Keywords: heterocycles, cycloaddition, leimgruber-batcho synthesis, reducing agents, cross-coupling reaction, cytotoxicity, human lung cancer
Current Organic Chemistry
Title: Reductive Cyclisation in the Synthesis of 5-Membered N-Heterocycles
Volume: 8 Issue: 16
Author(s): Petros G. Tsoungas and Andreas I. Diplas
Affiliation:
Keywords: heterocycles, cycloaddition, leimgruber-batcho synthesis, reducing agents, cross-coupling reaction, cytotoxicity, human lung cancer
Abstract: The versatility and potential of reductive cyclisation as a route to 5-membered N-heterocyclic structures of diverse complexity is demonstrated through selected examples.
Export Options
About this article
Cite this article as:
Tsoungas G. Petros and Diplas I. Andreas, Reductive Cyclisation in the Synthesis of 5-Membered N-Heterocycles, Current Organic Chemistry 2004; 8 (16) . https://dx.doi.org/10.2174/1385272043369755
DOI https://dx.doi.org/10.2174/1385272043369755 |
Print ISSN 1385-2728 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5348 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Synthesis and Evaluation of Novel Erucin Analogues as Potential Antitumor Compounds
Letters in Organic Chemistry Current Status of Clinical Trials for Glioblastoma
Reviews on Recent Clinical Trials Subject Index To Volume 9
Current Medicinal Chemistry Genistein Potentiates the Anti-cancer Effects of Gemcitabine in Human Osteosarcoma via the Downregulation of Akt and Nuclear Factor-κB Pathway
Anti-Cancer Agents in Medicinal Chemistry Specificity of Binding in Protein Kinases
Current Enzyme Inhibition Dual Roles of Sulforaphane in Cancer Treatment
Anti-Cancer Agents in Medicinal Chemistry Lemon Juice Mediated Synthesis of 3-Substituted Quinazolin-4(3H)-Ones and their Pharmacological Evaluation
Anti-Cancer Agents in Medicinal Chemistry MicroRNAs in Tumorigenesis
Current Pharmaceutical Biotechnology Molecular Imaging of Therapeutic Potential of Reporter Probes
Current Drug Targets Molecular Mechanism and Targets of the Antimicrobial Activity of Metal Nanoparticles
Current Topics in Medicinal Chemistry The Reciprocal Interaction: Chemotherapy and Tumor Microenvironment
Current Drug Discovery Technologies Editorial (Thematic Issue: Antiangiogenic Agents in the Management of Solid Malignancies)
Current Angiogenesis (Discontinued) Quantitative Structure-Activity Relationship Studies: Understanding the Mechanism of Tyrosine Kinase Inhibition
Current Enzyme Inhibition Embryonic Morphogenetic Field Induces Phenotypic Reversion in Cancer Cells. Review Article
Current Pharmaceutical Biotechnology Emerging Role of Stereotactic Radiotherapy (SRT) in the Treatment of Early Stage Non-Small Cell Lung Cancer
Current Cancer Therapy Reviews Features Identification for Phenotypic Classification Based on Genes and Gene Pairs
Current Bioinformatics Intracellular Redox State as Target for Anti-Influenza Therapy: Are Antioxidants Always Effective?
Current Topics in Medicinal Chemistry Genetic Polymorphisms of Drug Metabolizing Enzymes and Transporters: The Long Way from Bench to Bedside
Current Topics in Medicinal Chemistry Molecular Predictors of Efficacy to Anti-EGFR Agents in Colorectal Cancer Patients
Current Cancer Drug Targets Progress in the Development of Selective Inhibitors of Aurora Kinases
Current Topics in Medicinal Chemistry